Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. Our pharmaceutical-grade tirzepatide offers researchers a cost-effective alternative to tirzepatide costco options with superior purity and consistency.
The compound demonstrates significantly better efficacy in glucose control and weight loss research compared to similar compounds. As a dual agonist, tirzepatide shows greater affinity for GIP receptors than GLP-1 receptors, producing more pronounced effects in research settings.
Our tirzepatide powder features PEG modification in its sequence, enhancing water solubility while maintaining biological activity. This makes it particularly suitable for various research applications where solubility is crucial.
For researchers seeking tirzepatide costco alternatives, we offer competitive bulk pricing without compromising quality. Our production facilities maintain strict quality control to ensure batch-to-batch consistency in all research materials.
Note: This product is for research use only, not for human consumption. All orders are subject to verification of research purpose and institutional affiliation.